Tweet
Trends Microbiol
. 2025 Jan 13:S0966-842X(24)00324-X.
doi: 10.1016/j.tim.2024.12.008. Online ahead of print. ZBP1-driven cell death in severe influenza
David F Boyd 1 , Summer Vaughn Jordan 2 , Siddharth Balachandran 3
Affiliations
Influenza A virus (IAV) infections can cause life-threatening illness in humans. The severity of disease is directly linked to virus replication in the alveoli of the lower respiratory tract. In particular, the lytic death of infected alveolar epithelial cells (AECs) is a major driver of influenza severity. Recent studies have begun to define the molecular mechanisms by which IAV triggers lytic cell death. Z-form nucleic-acid-binding protein 1 (ZBP1) senses replicating IAV and drives programmed cell death (PCD) in infected cells, including apoptosis and necroptosis in AECs and pyroptosis in myeloid cells. Necroptosis and pyroptosis, both lytic forms of death, contribute to pathogenesis during severe infections. Pharmacological blockade of necroptosis shows strong therapeutic potential in mouse models of lethal influenza. We suggest that targeting ZBP1-initiated necroinflammatory cell lysis, either alone or in combination antiviral drugs, will provide clinical benefit in severe influenza.
Keywords: RIPK3; ZBP1; apoptosis; influenza A virus; necroptosis; pyroptosis.
. 2025 Jan 13:S0966-842X(24)00324-X.
doi: 10.1016/j.tim.2024.12.008. Online ahead of print. ZBP1-driven cell death in severe influenza
David F Boyd 1 , Summer Vaughn Jordan 2 , Siddharth Balachandran 3
Affiliations
- PMID: 39809680
- DOI: 10.1016/j.tim.2024.12.008
Influenza A virus (IAV) infections can cause life-threatening illness in humans. The severity of disease is directly linked to virus replication in the alveoli of the lower respiratory tract. In particular, the lytic death of infected alveolar epithelial cells (AECs) is a major driver of influenza severity. Recent studies have begun to define the molecular mechanisms by which IAV triggers lytic cell death. Z-form nucleic-acid-binding protein 1 (ZBP1) senses replicating IAV and drives programmed cell death (PCD) in infected cells, including apoptosis and necroptosis in AECs and pyroptosis in myeloid cells. Necroptosis and pyroptosis, both lytic forms of death, contribute to pathogenesis during severe infections. Pharmacological blockade of necroptosis shows strong therapeutic potential in mouse models of lethal influenza. We suggest that targeting ZBP1-initiated necroinflammatory cell lysis, either alone or in combination antiviral drugs, will provide clinical benefit in severe influenza.
Keywords: RIPK3; ZBP1; apoptosis; influenza A virus; necroptosis; pyroptosis.